Unrelated Umbilical Cord Blood Following HLA-haploidentical Hematopoietic Stem Cell Transplantation in Patients With β-thalassemia Major
Last updated on April 2022Recruitment
- Recruitment Status
- Unknown status
Inclusion Criteria
- < 18 year old
- β-thalassemia major
- Unrelated umbilical cord blood following Haplo-identical HSCT
- < 18 year old
- β-thalassemia major
- Unrelated umbilical cord blood following Haplo-identical HSCT
Exclusion Criteria
- Severe iron overload in heart by T2*
- Unrelated donor transplants
- ≥ 18 year old
- ...
- Severe iron overload in heart by T2*
- Unrelated donor transplants
- ≥ 18 year old
- HLA- matched related donors
- Unrelated umbilical cord blood transplants
Summary
- Conditions
- ?-thalassemia Major
- Thalassemia Major
- Type
- Interventional
- Design
- Allocation: N/A
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
Participation Requirements
- Age
- Younger than 1218 years
- Gender
- Both males and females
Inclusion Criteria
- < 18 year old
- β-thalassemia major
- Unrelated umbilical cord blood following Haplo-identical HSCT
- < 18 year old
- β-thalassemia major
- Unrelated umbilical cord blood following Haplo-identical HSCT
Exclusion Criteria
- Severe iron overload in heart by T2*
- Unrelated donor transplants
- ≥ 18 year old
- ...
- Severe iron overload in heart by T2*
- Unrelated donor transplants
- ≥ 18 year old
- HLA- matched related donors
- Unrelated umbilical cord blood transplants
Tracking Information
- NCT #
- NCT02126046
- Collaborators
- Not Provided
- Investigators
- Not Provided